Form 4: Varonis CFO Sells Shares Under 10b5-1 Plan

Varonis Systems CFO and COO Guy Melamed sold 42,705 shares of common stock for $57.72 per share under a pre-arranged 10b5-1 trading plan.

Summary

• Guy Melamed, CFO and COO of Varonis Systems Inc. (VRNS), sold 42,705 shares of the company's common stock.
• The transaction occurred on August 13, 2025.
• The shares were sold at a weighted average price of $57.72 per share, with individual transaction prices ranging from $57.50 to $57.99.
• Following this sale, Guy Melamed beneficially owns 427,897 shares of Varonis Systems common stock.
• The sale was executed pursuant to a Rule 10b5-1 trading plan, which was adopted by the reporting person in 2024.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly negative. While an insider sale is generally seen as a negative signal, the fact that it was conducted under a pre-arranged 10b5-1 plan mitigates the negative impact, suggesting it's for personal financial planning rather than a lack of confidence in the company.

Positives

• The sale was conducted under a Rule 10b5-1 trading plan, indicating it was pre-scheduled and not a reaction to recent negative company developments.

Negatives

• An insider sale, even under a 10b5-1 plan, reduces the insider's direct equity stake in the company.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4.

Industry Context

This Form 4 filing is a routine disclosure of an insider stock transaction. It does not provide information directly related to broader industry trends or competitive landscape, other than indicating an executive's portfolio management.

Comparison to Industry Standards

• Insider sales are common, especially for executives who receive significant equity compensation.
• The use of a Rule 10b5-1 plan is a standard practice for insiders to sell shares systematically and avoid accusations of trading on material non-public information. Many executives at comparable tech companies (e.g., Microsoft, Salesforce, Oracle) utilize 10b5-1 plans for liquidity and diversification.
• The volume of shares sold (42,705) represents a portion of the executive's holdings (427,897 remaining), which is typical for diversification rather than a complete divestment.

Stakeholder Impact

• Shareholders: The sale slightly reduces the CFO's direct ownership, which could be perceived as a minor negative, but the 10b5-1 plan context lessens this impact.

Key Dates

Recommendation

This Form 4 filing reports a routine insider sale executed under a pre-arranged 10b5-1 trading plan. Such sales are typically for personal financial management and diversification, not an indication of a change in company fundamentals or outlook. Therefore, this specific filing alone does not provide a strong basis for a 'buy' or 'sell' recommendation, suggesting a 'hold' position is appropriate based solely on this information. Investors should consider broader company performance, industry trends, and market conditions.

Keywords

Varonis Systems, VRNS, Insider Sale, Form 4, Guy Melamed, CFO, COO, 10b5-1 Plan, Equity Transaction, Stock Sale